Ambu A/S (OTCMKTS:AMBBY) Posts Quarterly Earnings Results

Ambu A/S (OTCMKTS:AMBBY) posted its quarterly earnings data on Wednesday. The company reported $0.07 earnings per share for the quarter, Zacks reports. Ambu A/S had a return on equity of 10.35% and a net margin of 10.00%.

Ambu A/S Stock Up 4.9%

Shares of OTCMKTS:AMBBY traded up $0.65 on Wednesday, hitting $13.85. 1,000 shares of the company traded hands, compared to its average volume of 744. The stock has a 50 day simple moving average of $13.61 and a 200-day simple moving average of $14.55. The company has a quick ratio of 1.63, a current ratio of 2.72 and a debt-to-equity ratio of 0.08. The company has a market cap of $3.25 billion, a PE ratio of 40.74 and a beta of 0.93. Ambu A/S has a 52 week low of $12.56 and a 52 week high of $20.24.

About Ambu A/S

Ambu A/S is a Denmark-based medical device company specializing in single-use diagnostic and life-supporting equipment for hospitals, clinics and emergency services. The company’s core focus lies in developing products that enhance patient safety, streamline clinical workflows and reduce the risk of cross-contamination. Ambu’s offerings span critical care solutions such as anesthesia and respiratory care devices, as well as advanced endoscopy systems for minimally invasive diagnostics and therapies.

Within its anesthesia and respiratory care segment, Ambu is known for its market-leading disposable resuscitators—commonly referred to as “Ambu bags”—as well as a range of airway management products, including laryngeal masks and endotracheal tubes.